CDMRP: Bone Marrow Failure Research Program Investigator-Initiated Research Award

The BMFRP Investigator-Initiated Research Award is intended to support meritorious research focused on BMF diseases. The nvestigator-Initiated Research Award offers a partnering option. 

Relevant diseases include (but are not limited to): 

• Aplastic Anemia

• Diamond-Blackfan Anemia

• Dyskeratosis Congenita/Telomere Biology Disorders

• Fanconi Anemia

• GATA2 Deficiency

• Induced BMF: Radiation/Chemical

• Myelodysplastic Syndromes

• Paroxysmal Nocturnal Hemoglobinuria

• Pearson’s Disease

• SAMD9/ SAMD9L Germline Mutations

• Severe Congenital Neutropenia

• Shwachman-Diamond Syndrome

• VEXAS Syndrome

Applications must address at least one focus area: 

• Understand the causes and progression of BMF diseases
• Find effective BMF treatments and cures

The FY23 BMFRP Investigator-Initiated Research Award will offer two funding levels with different intent:
Funding Level 1 (FL1): To support studies that further develop ideas, expand upon key discoveries, and have the potential to make significant advances in research, patient care, and/or quality of life.

Funding Level 2 (FL2): To support Investigational New Drug (IND)-enabling efforts.

It is expected that two (2) awards will be granted. 

Funding: Level 1- $675,000 total; Level 2- $850,000 total 
Duration: Level 1- 3 years; Level 2- 2 years 

Research Authority due date: 10.7.24

Pre application (required) due date: 17.7.24

Full proposal due date: 9.10.24